On Tuesday, COMSCORE, Inc. (NASDAQ:SCOR)’s shares declined -5.90% to $48.50.
COMSCORE, Inc. (SCOR) declared that it has attained Proximic, a Menlo Park, CA-based analytics company that offers solutions focused on bringing transparency to digital advertising for both buyers and sellers. Technology used in Proximic’s pre-bid solutions will power enhancements to brand safety and content categorization capabilities across comScore’s products, counting its Industry Trust offerings and its validated Campaign Essentials™ (vCE®) and Media Metrix® Multi-Platform product suites. The Proximic team will be joining comScore as part of the acquisition.
comScore, Inc. provides digital media analytics products and services for content publishers, advertisers, advertising agencies, and network operators primarily in the United States, Canada, Europe, Latin America, and Asia.
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL)’s shares dropped -11.89% to $4.00.
Rigel Pharmaceuticals, Inc. (RIGL) declared that it will report its first quarter 2015 financial results after market close on Thursday, May 7, 2015. Rigel senior administration will follow the declarement with a live conference call and webcast at 4:30pm Eastern Time (1:30pm Pacific Time) to talk about the financial results and provide an update on the Company’s clinical programs and pipeline.
Rigel Pharmaceuticals, Inc., a clinical-stage drug development company, engages in the discovery and development of small-molecule drugs for the treatment of inflammatory and autoimmune diseases, immuno-oncology related diseases, and muscle disorders.
At the end of Tuesday’s trade, Build-A-Bear Workshop, Inc (NYSE:BBW)‘s shares dipped -5.86% to $17.02.
Build-A-Bear Workshop, Inc (BBW) stated results for the 2015 first quarter ended April 4, 2015.
First Quarter 2015 Highlights (13 weeks ended April 4, 2015 contrast to the 13 weeks ended March 29, 2014):
- Merged net retail sales were $91.7 million, contrast to $96.8 million in the 2014 first quarter reflecting the negative impact of the one-week calendar shift due to fiscal year 2014 having a 53rd week. In addition, foreign currency exchange rate fluctuations negatively influenced net retail sales by $1.9 million primarily due to the strengthening of the US dollar;
- Merged comparable store sales raised 2%, which comprised of a flat performance in North America and a 13% enhance in Europe. First quarter fiscal 2015 comparable store sales are contrast to the thirteen-week period ended April 5, 2014;
- Retail gross margin improved to 46.8% from 43.5% in the 2014 first quarter;
Build-A-Bear Workshop, Inc. operates as a specialty retailer of plush animals and related products. It operates in three segments: Retail, International Franchising, and Commercial.
Merrimack Pharmaceuticals Inc (NASDAQ:MACK), ended its Tuesday’s trading session with -5.78% loss, and closed at $11.42.
Merrimack Pharmaceuticals Inc (MACK) announced the initiation of a randomized, double-blinded, placebo-controlled Phase 2 clinical trial of MM-141, a bispecific antibody targeting IGF-1R and ErbB3, in combination with nab-paclitaxel and gemcitabine, versus nab-paclitaxel and gemcitabine alone in patients with newly-diagnosed metastatic pancreatic cancer who have high serum levels of free IGF-1.
Merrimack Pharmaceuticals, Inc., a biopharmaceutical company, engages in discovering, developing, and preparing to commercialize medicines paired with companion diagnostics for the treatment of cancer primarily in the United States.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
